Generic Name |
|
|
abacavir
|
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
|
2 -
Non-Antineoplastic Hazardous
|
abacavir-dolutegravir-lamivudine
|
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NNRTI); HIV Integrase Inhibitors
|
2 -
Non-Antineoplastic Hazardous
|
abacavir-lamivudine
|
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
|
2 -
Non-Antineoplastic Hazardous
|
abacavir-lamivudine-zidovudine
|
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
|
2 -
Non-Antineoplastic Hazardous
|
abiraterone
|
Antineoplastic Agents
|
1 -
Antineoplastic Hazardous
|
acitretin
|
Keratolytic Agents
|
3 -
Reproductive Hazard
|
azaCITIDine
|
Antineoplastic Agents
|
1 -
Antineoplastic Hazardous
|
bendamustine
|
Antineoplastic Agents
|
1 -
Antineoplastic Hazardous
|
bortezomib
|
Antineoplastic Agents
|
1 -
Antineoplastic Hazardous
|
cidofovir
|
Nucleosides and Nucleotides
|
2 -
Non-Antineoplastic Hazardous
|
conjugated estrogens
|
Estrogens
|
2 -
Non-Antineoplastic Hazardous
|
conjugated estrogens topical
|
Estrogens
|
2 -
Non-Antineoplastic Hazardous
|
eriBULin
|
Antineoplastic Agents
|
1 -
Antineoplastic Hazardous
|
fluconazole
|
Azoles
|
3 -
Reproductive Hazard
|
fulvestrant
|
Antineoplastic Agents
|
1 -
Antineoplastic Hazardous
|
heroin
|
Opiate Agonist
|
4 -
Illicit Substances
|
methotrexate
|
Antineoplastic Agents; Disease-modifying Antirheumatic Drugs
|
1 -
Antineoplastic Hazardous
|
momelotinib
|
Antineoplastic Agents
|
0 -
N/A
|
nirogacestat
|
Antineoplastic Agents
|
0 -
N/A
|
pasireotide
|
Somatostatin Agonists
|
3 -
Reproductive Hazard
|